These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 34486297

  • 1. Hepatic and Renal Impacts of Lesinurad on Experimental Hyperuricemia: Biochemical, Molecular and Pathological Investigations.
    Saeed Alghamdi Y.
    Pak J Biol Sci; 2021 Jan; 24(7):780-789. PubMed ID: 34486297
    [Abstract] [Full Text] [Related]

  • 2. Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study.
    Alghamdi YS, Soliman MM, Nassan MA.
    BMC Pharmacol Toxicol; 2020 Feb 10; 21(1):10. PubMed ID: 32041665
    [Abstract] [Full Text] [Related]

  • 3. Lesinurad: A Review in Hyperuricaemia of Gout.
    Deeks ED.
    Drugs Aging; 2017 May 10; 34(5):401-410. PubMed ID: 28425024
    [Abstract] [Full Text] [Related]

  • 4. Lesinurad: First Global Approval.
    Hoy SM.
    Drugs; 2016 Mar 10; 76(4):509-16. PubMed ID: 26861027
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Lesinurad in Patients with Hyperuricemia Associated with Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Wu JY, Chang YT, Lin YC, Lee CH, Loh EW, Wu MY, Chang YS, Tam KW.
    Pharmacotherapy; 2018 Nov 10; 38(11):1106-1119. PubMed ID: 30246299
    [Abstract] [Full Text] [Related]

  • 6. Hypouricemic and Nephroprotective Effects of Emodinol in Oxonate-Induced Hyperuricemic Mice are Mediated by Organic Ion Transporters and OIT3.
    Hui W, Yongliang Y, Yongde C, Guo L, Li L, Zhonglin Y, Hui J, Qinghua H.
    Planta Med; 2016 Mar 10; 82(4):289-297. PubMed ID: 26584455
    [Abstract] [Full Text] [Related]

  • 7. Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics.
    Aksenov S, Peck CC, Eriksson UG, Stanski DR.
    Physiol Rep; 2018 Mar 10; 6(5):. PubMed ID: 29488355
    [Abstract] [Full Text] [Related]

  • 8. Lesinurad (Zurampic) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2016 Nov 21; 58(1508):148-150. PubMed ID: 27849193
    [No Abstract] [Full Text] [Related]

  • 9. Molecular and Histopathological Study on the Ameliorative Impacts of Petroselinum Crispum and Apium Graveolens against Experimental Hyperuricemia.
    Soliman MM, Nassan MA, Aldhahrani A, Althobaiti F, Mohamed WA.
    Sci Rep; 2020 Jun 11; 10(1):9512. PubMed ID: 32528050
    [Abstract] [Full Text] [Related]

  • 10. The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout.
    Baumgartner S, Yeh LT, Shen Z, Kerr B, Manhard K, Quart B.
    J Clin Pharmacol; 2018 Sep 11; 58(9):1164-1170. PubMed ID: 29733441
    [Abstract] [Full Text] [Related]

  • 11. Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice.
    Hu QH, Zhang X, Wang X, Jiao RQ, Kong LD.
    Eur J Nutr; 2012 Aug 11; 51(5):593-606. PubMed ID: 21909718
    [Abstract] [Full Text] [Related]

  • 12. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
    Miner JN, Tan PK, Hyndman D, Liu S, Iverson C, Nanavati P, Hagerty DT, Manhard K, Shen Z, Girardet JL, Yeh LT, Terkeltaub R, Quart B.
    Arthritis Res Ther; 2016 Oct 03; 18(1):214. PubMed ID: 27716403
    [Abstract] [Full Text] [Related]

  • 13. Anti-hyperuricemic and nephroprotective effects of Modified Simiao Decoction in hyperuricemic mice.
    Hua J, Huang P, Zhu CM, Yuan X, Yu CH.
    J Ethnopharmacol; 2012 Jun 26; 142(1):248-52. PubMed ID: 22575704
    [Abstract] [Full Text] [Related]

  • 14. Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients.
    Presa M, Pérez-Ruiz F, Oyagüez I.
    Clin Rheumatol; 2019 Dec 26; 38(12):3521-3528. PubMed ID: 31420811
    [Abstract] [Full Text] [Related]

  • 15. Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy.
    Ruggeri M, Basile M, Drago C, Rolli FR, Cicchetti A.
    Pharmacoeconomics; 2018 May 26; 36(5):625-636. PubMed ID: 29557073
    [Abstract] [Full Text] [Related]

  • 16. New medications in development for the treatment of hyperuricemia of gout.
    Diaz-Torné C, Perez-Herrero N, Perez-Ruiz F.
    Curr Opin Rheumatol; 2015 Mar 26; 27(2):164-9. PubMed ID: 25603039
    [Abstract] [Full Text] [Related]

  • 17. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
    Chen G, Tan ML, Li KK, Leung PC, Ko CH.
    J Ethnopharmacol; 2015 Dec 04; 175():14-20. PubMed ID: 26344851
    [Abstract] [Full Text] [Related]

  • 18. Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).
    Bardin T, Keenan RT, Khanna PP, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, So A.
    Ann Rheum Dis; 2017 May 04; 76(5):811-820. PubMed ID: 27821644
    [Abstract] [Full Text] [Related]

  • 19. [Mangiferin promotes uric acid excretion and kidney function improvement and modulates related renal transporters in hyperuricemic mice].
    Hu QH, Zhang X, Wang Y, Kong LD.
    Yao Xue Xue Bao; 2010 Oct 04; 45(10):1239-46. PubMed ID: 21348301
    [Abstract] [Full Text] [Related]

  • 20. Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine.
    Wu XH, Wang CZ, Wang SQ, Mi C, He Y, Zhang J, Zhang YW, Anderson S, Yuan CS.
    J Ethnopharmacol; 2015 Mar 13; 162():362-8. PubMed ID: 25617746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.